Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy
Zahra Pervaiz, Lobke Gierman, Gabriela Silva, Bente Skei, Johanne Rakner, Anne Beversmark, Liv Thomsen, Line Bjørge and Ann-Charlotte Iversen
DOI: https://doi.org/10.7861/clinmedicine.19-2-s104
Clin Med March 2019 Zahra Pervaiz
ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
BSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Lobke Gierman
ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
Gabriela Silva
ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
CSt Olavs Hospital, Trondheim University Hospital, Trondheim
Bente Skei
ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
Johanne Rakner
ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
Anne Beversmark
CSt Olavs Hospital, Trondheim University Hospital, Trondheim
Liv Thomsen
ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
DDepartment of Gynecology and Obstetrics, Haukeland University Hospital
Line Bjørge
DDepartment of Gynecology and Obstetrics, Haukeland University Hospital
ECentre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway
Ann-Charlotte Iversen
ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
Article Information
vol. 19 no. Suppl 2 s104
Published By:
Print ISSN:
Online ISSN:
History:
- Published online September 17, 2020.
Copyright & Usage:
© Royal College of Physicians 2019. All rights reserved.
Author Information
- Zahra PervaizAB,
- Lobke GiermanA,
- Gabriela SilvaAC,
- Bente SkeiA,
- Johanne RaknerA,
- Anne BeversmarkC,
- Liv ThomsenAD,
- Line BjørgeDE and
- Ann-Charlotte IversenA
- ACentre of Molecular Inflammation Research and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
- BSheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
- CSt Olavs Hospital, Trondheim University Hospital, Trondheim
- DDepartment of Gynecology and Obstetrics, Haukeland University Hospital
- ECentre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway
Article usage
Article Tools
Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy
Zahra Pervaiz, Lobke Gierman, Gabriela Silva, Bente Skei, Johanne Rakner, Anne Beversmark, Liv Thomsen, Line Bjørge, Ann-Charlotte Iversen
Clinical Medicine Mar 2019, 19 (Suppl 2) s104; DOI: 10.7861/clinmedicine.19-2-s104
Citation Manager Formats
Toll-like receptor 3 expression and activation at the maternal-fetal interface in pregnancy
Zahra Pervaiz, Lobke Gierman, Gabriela Silva, Bente Skei, Johanne Rakner, Anne Beversmark, Liv Thomsen, Line Bjørge, Ann-Charlotte Iversen
Clinical Medicine Mar 2019, 19 (Suppl 2) s104; DOI: 10.7861/clinmedicine.19-2-s104
Related Articles
- No related articles found.
Cited By...
- No citing articles found.